Drug intelligence / Profile preview

alenia

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Inhalation, Oral
01

Overview

Alenia is a brand name used internationally for different pharmaceutical products depending on the country. In Brazil, Alenia contains budesonide and formoterol fumarate dihydrate, making it a combination inhaler used primarily for the management of asthma and chronic obstructive pulmonary disease (COPD). Budesonide is an inhaled corticosteroid that reduces inflammation in the airways, while formoterol is a long-acting beta2-adrenergic agonist (LABA) that relaxes bronchial smooth muscle to improve airflow. In Bangladesh, Alenia contains esomeprazole, which is a proton pump inhibitor used to reduce stomach acid production in conditions such as gastroesophageal reflux disease (GERD). The specific mechanism of action depends on the formulation: - For budesonide/formoterol: anti-inflammatory effects via glucocorticoid receptor activation and bronchodilation via beta2-adrenoceptor agonism. - For esomeprazole: inhibition of gastric H+/K+ ATPase enzyme system.

Brand names
Alenia
Other names
budesonide + formoterol fumaratebudesonide + formoterol fumarate dihydrate
02

Targets

GR (Glucocorticoid receptor)ADRB2 (β2)

Beyond the preview

Go deeper on alenia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alenia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call